New drug aims to restart periods in women with stress-related amenorrhea

NCT ID NCT07235917

Recruiting now Disease control Sponsor: Regeneron Pharmaceuticals Source: ClinicalTrials.gov ↗

First seen Nov 19, 2025 · Last updated May 09, 2026 · Updated 18 times

Summary

This study tests an experimental drug called mibavademab in 34 women with functional hypothalamic amenorrhea (FHA), a condition where stress, low body weight, or excessive exercise stops periods. The goal is to see if the drug can restore the hormones needed for ovulation and improve bone health. Participants will receive either the drug or a placebo, and researchers will monitor hormone levels, side effects, and safety.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FUNCTIONAL HYPOTHALAMIC AMENORRHEA (FHA) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Arensia Exploratory Medicine Clinic
RECRUITING

Phoenix, Arizona, 85015, United States
Focus Clinical Research
RECRUITING

West Hills, California, 91307, United States
OBGYN Associates of Erie
RECRUITING

Erie, Pennsylvania, 16507, United States
Tidewater Clinical Research - Tidewater Physicians for Women
RECRUITING

Norfolk, Virginia, 23502, United States
Zillan Clinical Research
RECRUITING

Houston, Texas, 77082, United States

Conditions

Explore the condition pages connected to this study.

FUNCTIONAL HYPOTHALAMIC AMENORRHEA (FHA)